NovoCure Ltd Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.09 | 70,364 | 2,257,699 | 69,318 | 139.7 K to 69.3 K (-50.37 %) |
| Jun 21 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.04 | 8,308 | 266,148 | 139,682 | 148 K to 139.7 K (-5.61 %) |
| Jun 21 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.00 | 621 | 19,872 | 147,990 | 148.6 K to 148 K (-0.42 %) |
| Jun 19 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.00 | 22,289 | 713,248 | 148,611 | 170.9 K to 148.6 K (-13.04 %) |
| Jun 19 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 31.09 | 30,000 | 932,802 | 1,101,054 | 1.1 M to 1.1 M (-2.65 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 11.46 | 37,500 | 429,750 | 37,500 | |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 14.37 | 30,750 | 441,878 | 235,335 | |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 11.46 | 37,500 | 429,750 | 107,832 | 70.3 K to 107.8 K (+53.32 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 14.37 | 30,750 | 441,878 | 70,332 | 39.6 K to 70.3 K (+77.69 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 31.64 | 30,000 | 949,269 | 1,131,054 | 1.2 M to 1.1 M (-2.58 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.00 | 200 | 6,400 | 170,900 | 171.1 K to 170.9 K (-0.12 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.00 | 11,720 | 375,040 | 171,100 | 182.8 K to 171.1 K (-6.41 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 32.00 | 2,800 | 89,600 | 182,820 | 185.6 K to 182.8 K (-1.51 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 31.64 | 19,694 | 623,118 | 185,620 | 205.3 K to 185.6 K (-9.59 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 30.34 | 28,150 | 854,071 | 205,314 | 233.5 K to 205.3 K (-12.06 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 29.31 | 26,782 | 784,980 | 233,464 | 260.2 K to 233.5 K (-10.29 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 28.43 | 149,878 | 4,261,032 | 260,246 | 410.1 K to 260.2 K (-36.54 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.15 | 68,250 | 487,988 | 204,750 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.48 | 59,130 | 442,292 | 0 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.03 | 218,781 | 1,538,030 | 0 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 31.74 | 4,131 | 131,118 | 39,582 | 43.7 K to 39.6 K (-9.45 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 30.26 | 1,800 | 54,468 | 43,713 | 45.5 K to 43.7 K (-3.95 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 29.36 | 114,934 | 3,374,462 | 45,513 | 160.4 K to 45.5 K (-71.63 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.15 | 68,250 | 487,988 | 160,447 | 92.2 K to 160.4 K (+74.03 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.48 | 59,130 | 442,292 | 92,197 | 33.1 K to 92.2 K (+178.82 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 28.60 | 225,296 | 6,443,466 | 33,067 | 258.4 K to 33.1 K (-87.20 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.03 | 218,781 | 1,538,030 | 258,363 | 39.6 K to 258.4 K (+552.73 %) |
| Jun 04 2018 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Option Exercise | A | 31.45 | 45,137 | 1,419,559 | 45,137 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | A | 0.00 | 8,906 | 0 | 8,906 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | A | 31.45 | 17,891 | 562,672 | 17,891 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Hung David | Director | Option Exercise | A | 31.45 | 45,137 | 1,419,559 | 45,137 | |
| Jun 04 2018 | NVCR | NovoCure Ltd | Hung David | Director | Option Exercise | A | 31.45 | 45,137 | 1,419,559 | 45,137 |